• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC MYOSURE XL HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC MYOSURE XL HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM Back to Search Results
Model Number 50-501XL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Air Embolism (1697)
Event Date 05/16/2019
Event Type  Injury  
Manufacturer Narrative
Lot and serial number of the disposable device not provided by the complainant, therefore the expiration date is not known.The device has not yet been returned therefore, a failure analysis of the complaint device cannot be completed.If the device is returned and evaluation completed, a supplemental medwatch will be filed.Lot number of the disposable device not provided by the complainant, therefore the manufacture date is not known.Device history record (dhr) review was unable to be conducted for the disposable device or the radio frequency controller as the identification numbers were not provided by the complainant.
 
Event Description
It was reported to a hologic representative by a physician that a few months ago he was performing a fibroid removal procedure and suddenly the patient oxygen saturation level dropped.The proceduralist and anesthesiologist both confirmed that there were no error messages or alarms coming from the device and that the procedure was uncomplicated until about 45 minutes in when the patient began to desaturate.Fio2 was increased to 100% and respirations were assisted by hand but her oxygenation continued to deteriorate over 5 minutes.A cardiorespiratory arrest was called and subsequently the patient was emergently intubated.Despite good air entry bilaterally, the patient oxygenation did not improve.The patient was then positioned steep head down and her saturation returned to normal within 30 seconds.Cpr was never required.The patient was diagnosed with an air embolism related to hysteroscopic insufflation.It was noted by the gynae registrar that although the procedure was uncomplicated, the field of view became blood stained right before the initial desaturation.Patient blood pressure required support.A low dose adrenaline infusion was given along with an albumex and crystalloid infusion.Patient was transferred to the icu for recovery and was extubated the following day.No additional details available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE XL HYSTEROSCOPIC TISSUE REMOVAL SYSTEM
Type of Device
UTERINE TISSUE REMOVAL SYSTEM
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer Contact
kelsea lyver
250 campus drive
marlborough, MA 01752
5082636130
MDR Report Key9467855
MDR Text Key172189553
Report Number1222780-2019-00280
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K122498
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 11/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number50-501XL
Device Catalogue Number50-501XL
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/28/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Other; Required Intervention;
-
-